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Vaccination Coverage Among American Indian and
Alaska Native Children, 2006–2010
WHAT’S KNOWN ON THIS SUBJECT: Disparities in vaccination
coverage between American Indian/Alaska Native and white
children previously existed between 2001 and 2004 but were not
present in 2005.
WHAT THIS STUDY ADDS: This study updates a previous study by
analyzing data through 2010 and found that these gains have been
maintained.
abstract
BACKGROUND AND OBJECTIVES: A previous study on vaccination cov-
erage in the American Indian/Alaska Native (AI/AN) population found
that disparities in coverage between AI/AN and white children existed
from 2001 to 2004 but were absent in 2005. The objective of this study
was to describe vaccination coverage levels for AI/AN children aged 19-
35 months in the United States between 2006 and 2010, examining
whether gains found for AI/AN children in 2005 have been sustained.
METHODS: Data from the 2006 through 2010 National Immunization
Surveys were analyzed. Groups were defined as AI/AN (alone or in
combination with any other race and excluding Hispanics) and
white-only non-Hispanic children. Comparisons in demographics and
vaccination coverage were made.
RESULTS: Demographic risk factors often associated with underimmu-
nization were significantly higher for AI/AN respondents compared with
white respondents in most years studied. Overall, vaccination coverage
was similar between the 2 groups in most years, although coverage
with 4 or more doses of pneumococcal conjugate vaccine was lower for
AI/AN children in 2008 and 2009, as was coverage with vaccine series
measures the series in 2006 and 2009. When stratified by geographic
regions, AI/AN children had coverage that was similar to or higher
than that of white children for most vaccines in most years studied.
CONCLUSIONS: The gains in vaccination coverage found in 2005 have
been maintained. The absence of disparities in coverage with most
vaccines between AI/AN children and white children from 2006
through 2010 is a clear success. These types of periodic reviews
are important to ensure we remain vigilant. Pediatrics 2012;130:
e1592–e1599
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ABBREVIATIONS
AI/AN—American Indian/Alaska Native
CHSDA—contract health services delivery areas
CI—confidence interval
DTaP—$Diphtheria and tetanus toxoids and pertussis vaccine,
or diphtheria and tetanus toxoids, or diphtheria and tetanus
toxoids and any acellular pertussis vaccine
Hib—Haemophilus influenzae type b
HepB—hepatitis B
IHS—Indian Health Service
I/T/U—Indian Health Service, Tribal, Urban Indian health facility
MMR—measles, mumps, rubella
MSA—Metropolitan Statistical Area
NIS—National Immunization Survey
PCV—pneumococcal conjugate vaccine
Var—varicella
VPD—vaccine-preventable diseases
4:3:1:3:3:1—$4 doses, diphtheria and tetanus toxoids and per-
tussis vaccine, diphtheria and tetanus toxoids, or diphtheria and
tetanus toxoids and any pertussis vaccine, $3 doses of oral or
inactivated polio vaccine, $1 dose of measles, mumps, and ru-
bella vaccine,$3 doses of Haemophilus influenzae type b vaccine,
$3 doses of hepatitis B vaccine, and$1 dose of varicella vaccine
4:3:1:x:3:1—the 4:3:1:3:3:1 series excluding the Hib vaccine
4:3:1:3:3:1:4—$4 doses diphtheria and tetanus toxoids and per-
tussis vaccine, diphtheria and tetanus toxoids, or diphtheria and
tetanus toxoids and any pertussis vaccine, $3 doses of oral or
inactivated polio vaccine, $1 dose of measles, mumps, and ru-
bella vaccine,$3 doses of Haemophilus influenzae type b vaccine,
$3 doses of hepatitis B vaccine, $1 dose of varicella vaccine,
and $4 doses of pneumococcal conjugate vaccine
4:3:1:x:3:1:4—the 4:3:1:3:3:1:4 series excluding the Hib vaccine
(Continued on last page)
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During the prevaccine era in the Unit-
ed States, the American Indian and
Alaska Native (AI/AN) population suf-
fered disproportionately from vaccine-
preventable diseases (VPDs) such as
Haemophilus influenzae type b (Hib),
invasive pneumococcal disease, hepa-
titis A, and hepatitis B.1 While routine
childhood vaccination resulted in large
declines in VPDs, maintaining high
vaccination coverage is important, es-
pecially for populations at increased
risk of disease. The AI/AN population
remains vulnerable to VPDs due to risk
factors such as higher background
rates of disease, household crowding,
and lack of running water in some AI/
AN communities.1–3 Studies have also
shown that many of the risk factors
associated with underimmunization
are more prevalent among AI/AN chil-
dren compared with white children.4,5
A previous study on vaccination cov-
erage in this population found that
nationally, disparities in vaccine cov-
erage between AI/AN and white chil-
dren existed from 2001 through 2004
but were absent in 20054; a 2010 study
in North Dakota, however, found that AI
children were significantly less likely to
be up to date with their vaccinations
compared with white children.6
According to the 2010 census, the AI/AN
population represents ∼1.7% of the US
population7. AI/AN people receive
health care from a variety of sources
including the Indian Health Service
(IHS) and private and/or public health
insurance programs.8,9 The IHS is
a federal health program for AI/AN
people that provides care through
a network of IHS, tribal, and urban In-
dian health facilities (I/T/U) to eligible
AI/AN people. Approximately 2 million
AI/AN people, 38% of the total US AI/AN
population, are eligible to receive care
at these predominantly rural I/T/U
health facilities.10 However, some AI/
AN people who are eligible for care
may not reside near an I/T/U facility, as
the majority of AI/AN people reside in
urban areas.11,12 In addition, some AI/
AN people are not eligible to receive
care from the I/T/U system because
they are not enrolled members of
a federally recognized tribe. While IHS
monitors vaccination coverage among
AI/AN children served by an I/T/U fa-
cility,13 it cannot produce national
estimates of vaccination coverage for
the AI/AN population.
Theoverall objective of this studywas to
describe vaccination coverage levels
for AI/AN children in the United States
between 2006 and 2010, examining
whether the gains found for AI/AN
children in 20054 have been sustained.
METHODS
Data from the 2006 through the 2010
National Immunization Surveys (NIS)
were analyzed. The NIS is an ongoing,
national, random-digit-dial telephone
surveyofhouseholdswithchildren19 to
35 months old at the time of interview.
The household telephone survey is fol-
lowed by a survey mailed to the im-
munization providers identified during
the telephone survey and for which
permission was granted. All vaccina-
tion coverage estimates are based on
provider-reported vaccinations. The
household response rates foreach year
of the NIS studied (2006–2010) as de-
fined by the Council of American Survey
Research Organizations (CASRO)14 were
64.5%, 64.9%, 63.2%, 63.9%, and 63.8%,
respectively. Adequate provider vacci-
nation records were obtained for 70.4%
of children with completed household
interviews in 2006 (n = 21 044), 68.6% in
2007 (n = 17 017), 71.0% in 2008 (n = 18
430), 70.7% in 2009 (n = 17 313), and
71.2% in 2010 (n = 17 004).15–19 Meth-
odological details of the NIS have been
previously published.20
Vaccination Coverage Definitions
Vaccination coverage assessed in this
study included$4 doses of diphtheria
and tetanus toxoids and pertussis
vaccine, or diphtheria and tetanus
toxoids, or diphtheria and tetanus tox-
oids and any acellular pertussis vac-
cine (4+DTaP), $3 doses of poliovirus
vaccine (3+polio),$1 dose of measles,
mumps, and rubella (1+MMR) vaccine,
$3 doses of Haemophilus influenza
type b (31Hib) vaccine, $3 doses of
hepatitis B (3+HepB) vaccine,$1 dose
of varicella (1+Var) vaccine, and $4
doses of pneumococcal conjugate (4
+PCV) vaccine. In addition, we exam-
ined coverage with the combined 4
+DTaP, 3+polio, 1+MMR, 3+Hib, 3+HepB,
and 1+Var vaccine series, referred to
as the 4:3:1:3:3:1 series, and coverage
with this series plus 4+PCV, referred to
as the 4:3:1:3:3:1:4 series. Finally, be-
cause of the Hib vaccine shortage from
2007 to 2009,21 we analyzed coverage
for these 2 series without Hib vaccine
(4:3:1:x:3:1, 4:3:1:x:3:1:4).
Race Variable Definition
During the telephone portion of the NIS,
the parent/guardian of the child was
asked a series of questions about the
race/ethnicity of the child. These in-
cluded: “Is [child] of Hispanic or Latino
origin?” and “Now, I am going to read
a list of categories. Please choose one
or more of the following categories to
describe [child’s] race. Is [child] white,
black or African American, American
Indian, Alaska native, Asian, native Ha-
waiian or other Pacific Islander?” By
using responses to these questions, we
defined white as all non-Hispanic chil-
dren who were identified by their
parents as white alone, and AI/AN as all
non-Hispanic children who were iden-
tified by their parents as either AI/AN
alone or AI/AN in combination with any
other race. Hispanic children were ex-
cluded from the AI/AN definition as this
designation may include American
Indians from Central or South America.
To determine if there were differences
in coverage estimates depending on
ARTICLE
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the population definition used for AI/
AN, we compared vaccination cover-
age estimates for AI/AN alone to AI/AN
in combination with another race. All
results refer to the combined group of
AI/AN alone or in combination with
another race.
Demographic Variable Definitions
Demographic characteristics of the
children in the sample were obtained
during the telephone interview of the
parent/guardian, as part of routine NIS
data collection. Poverty level was de-
termined by using household reported
income level, numberof people reported
living in the household and US pov-
erty thresholds. Characteristics of
providers are provider-reported (ie,
provider type). Three additional geo-
graphic variables were included: IHS
Contract Health Service Delivery
Areas, or CHSDAs, are defined by IHS
and represent the catchment area for
IHS-funded facilities. For regional com-
parisons, the IHS administrative areas
were combined into 6 larger regions as
has been done in previous studies.22
Lastly, Metropolitan Statistical Area
(MSA) was used for urban versus rural
comparisons.
Statistical Methods
The percentage of AI/AN children who
were vaccinated was compared with
the percentage of white children vac-
cinated by using Wald x2 tests. Pro-
portions are reported along with 95%
confidence intervals (CIs). Data were
weighted to adjust for households
having multiple telephone lines, non-
assessment of households without tel-
ephones, household unit nonresponse,
provider nonresponse, and to reflect
population demographic totals. A 2-
sided significance level of .05 was
adopted for all statistical tests. Analysis
were conducted by using SAS, release
9.2 (SAS, Cary, NC) and SUDAAN, release
10.0 (Research Triangle Institute, Re-
search Triangle Park, NC) to take into
account the complex nature of the
survey.
RESULTS
Therewerenodifferences invaccination
coverage estimates between children
who were AI/AN-only compared with AI/
AN in combination with another race
with theoneexceptionof3+HepB in2008
(91.5% vs 98.6%, P = .01). All subsequent
AI/AN results refer to the combined
group of AI/AN alone or in combination
with another race. AI/AN sample sizes
are included in Table 1, and ranged
from 421 to 519 in any given year.
For all 5 years examined, AI/AN children
were more likely than white children to
live below the poverty level, have younger
mothers, and have mothers with less
education (Table 1). Mothers of AI/AN
children were also less likely than
mothers of white children to have ever
been married. In 2006–2008, AI/AN chil-
dren were significantly more likely to live
in a household with more children; ad-
ditional results are presented in Table 1.
Overall there were no significant dif-
ferences in vaccination coverage be-
tween AI/AN andwhite childrenwith the
following vaccines in any of the 5
survey years: 4+DTaP, 3+polio, 3+Hib, or
3+HepB (Table 2 and Fig 1). In 2007, AI/
AN children had higher 1+Var vaccine
coverage than white children (92.8% vs
89.2%, P , .05), and in 2008, AI/AN
children had higher 1+MMR coverage
than white children (95.3% vs 91.3%, P
, .01). AI/AN children had significantly
lower 4+PCV coverage than white
children in both 2008 (74.9% vs 81.4%)
and 2009 (71.4% vs 83.4%; both P ,
.05); however, coverage did not differ in
2010. There were no significant differ-
ences between AI/AN and white chil-
dren in the 4:3:1:3:3:1 vaccination
series in any of the years studied. In
2006 and 2009, coverage with the
4:3:1:3:3:1:4 series was lower for AI/AN
children (51.2% vs 62.7% in 2006; 52.3%
vs 64.1% in 2009, both P , .05) and in
2009 coverage with the 4:3:1:x:3:1:4 se-
ries was lower for AI/AN children
(58.1% vs 72.4%, P , .01).
There were some differences in vacci-
nation coverage levels between AI/AN
children and white children in all 6
regions (Table 3). For the Northern
Plains region in 2006, AI/AN children
had lower coverage with 41DTaP, 31
polio, and 31Hib vaccines compared
with white children and lower 4:3:1:
x:3:1:4 coverage in 2009, although cov-
erage in other years was not signifi-
cantly different. Vaccination coverage
levels for all other regions for all other
years revealed that AI/AN children had
either the same or higher coverage
compared with white children (Table
3). For all years studied, between 63%
and 69% of AI/AN children resided in
a CHSDA county. There were no signif-
icant differences in vaccine coverage
among AI/AN children residing in
a CHSDA county compared with AI/AN
children not residing in a CHSDA
county. There were few differences in
coverage between AI/AN children re-
siding in an MSA versus non-MSA; cov-
erage with 4:3:1:3:3 (2006), 3+polio
(2007), and 11MMRand 11Var vaccines
(2008) were higher among AI/AN chil-
dren residing in a non-MSA compared
with those residing in an MSA. There
were no differences in coverage for
2009 or 2010.
DISCUSSION
From 2006 through 2010, few differ-
ences in vaccination coverage between
AI/AN and white children were found.
Indeed, insomeregions (Southwestand
Alaska), coverage for AI/AN children
was frequently higher than that for
white children. Instances of signifi-
cantly lower coverage for AI/AN chil-
dren were relatively rare, and by 2010
there was no evidence of vaccination
coverage disparities between AI/AN
children and white children. These
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findings suggest that programs like the
Vaccines for Children program that
began in 1994, and provides free vac-
cine for AI/AN children younger than 19
years of age,23 as well as health care
infrastructure improvements and vac-
cine delivery strategies used by I/T/U
facilities,1,4,5 have been successful in
improving immunization coverage for
AI/AN children across the country.
Due to the 2008 and 2009 Hib vaccine
shortage, the overall decrease in cov-
erage with the Hib vaccine and the se-
ries containing Hib vaccine in those
years is not unexpected.24 To ensure
vaccine was provided to those at
higher risk, the Advisory Committee on
Immunization Practices (ACIP) recom-
mended that AI/AN children continue
to receive the full Hib series, and
PedvaxHib vaccine from the CDC
stockpile was made available for use
in this population.25 In 2009, coverage
with the 4:3:1:3:3:1 series nationally
was higher for AI/AN children com-
pared with white children. There was
no difference in Hib vaccine coverage
among AI/AN children compared with
white children nationally, although 2
IHS regions (Alaska, Southwest) did
achieve higher Hib coverage among AI/
AN children in 2008 and 2009. Both
Alaska and the Southwest used Ped-
vaxHib vaccine almost exclusively even
before the shortage, whereas other
regions used a mix of Hib products,
which may explain why the higher Hib
vaccine coverage was limited to these
regions. Higher coverage with other
vaccines in both these regions in 2008
and in Alaska in 2009, however, suggest
that the AI/AN Hib recommendation was
not the only contributing factor to the
increased coverage reported among
AI/AN children in these regions. Rea-
sons for increased coverage in these 2
regions may be related to population
characteristics such as geographical
concentration (eg reservations/villages)
with an I/T/U facility in close proximityTA
BL
E
2
Va
cc
in
at
io
n
Co
ve
ra
ge
of
AI
/A
Na
an
d
W
hi
te
-O
nl
y
Ch
ild
re
n,
NI
S,
20
06
–
20
10
,U
ni
te
d
St
at
es
20
06
20
07
20
08
20
09
20
10
AI
/A
N
W
hi
te
AI
/A
N
W
hi
te
AI
/A
N
W
hi
te
AI
/A
N
W
hi
te
AI
/A
N
W
hi
te
%
6
95
%
CI
n
%
6
95
%
CI
n
P
%
6
95
%
CI
n
%
6
95
%
CI
n
P
%
6
95
%
CI
n
%
6
95
%
CI
n
P
%
6
95
%
CI
n
%
6
95
%
CI
n
P
%
6
95
%
CI
n
%
6
95
%
CI
n
P
4+
DT
aP
77
.5
6
11
.4
41
6
86
.6
6
1.
1
10
49
8
.1
5
85
.4
6
4.
7
35
4
85
.3
6
1.
2
89
79
.9
6
84
.3
6
5.
2
40
0
85
.0
6
1.
2
96
89
.7
9
83
.8
6
5.
6
34
9
85
.8
6
1.
1
92
46
.4
8
77
.0
6
7.
4
38
6
84
.5
6
1.
3
90
65
.0
6
3+
Po
lio
89
.9
6
5.
3
46
5
93
.3
6
0.
7
11
19
2
.2
1
92
.5
6
3.
8
39
9
92
.6
6
0.
9
97
23
.9
7
93
.3
6
3.
6
44
8
93
.6
6
0.
8
10
56
8
.9
0
92
.6
6
5.
1
39
6
93
.3
6
0.
8
10
07
6
.7
9
91
.9
6
4.
3
45
3
93
.2
6
0.
8
98
27
.5
6
1+
M
M
R
89
.1
6
4.
2
46
0
92
.8
6
0.
7
11
11
8
.0
7
94
.0
6
2.
9
39
6
92
.1
6
0.
8
95
91
.2
2
95
.3
6
2.
9
45
0
91
.3
6
1.
0
10
31
0
.0
1
89
.4
6
6.
1
38
7
90
.8
6
0.
9
97
54
.6
5
90
.2
6
5.
0
44
4
90
.6
6
0.
9
95
61
.8
8
3+
Hi
b
91
.3
6
3.
6
46
3
94
.1
6
0.
8
11
31
2
.1
2
92
.2
6
3.
7
39
5
92
.9
6
0.
9
97
60
.7
0
90
.2
6
4.
0
42
6
90
.8
6
0.
9
10
19
4
.7
5
87
.5
6
5.
4
36
4
82
.9
6
1.
2
88
18
.1
2
88
.7
6
4.
7
43
2
90
.3
6
1.
2
95
53
.5
1
3+
He
pB
94
.2
6
2.
6
47
8
93
.8
6
0.
7
11
18
5
.8
0
93
.4
6
3.
2
39
6
92
.5
6
0.
9
97
09
.6
0
94
.6
6
3.
1
44
9
93
.4
6
0.
8
10
53
3
.4
8
93
.9
6
3.
2
39
1
92
.3
6
0.
9
99
67
.3
5
93
.5
6
4.
0
45
5
91
.4
6
0.
9
96
06
.3
4
1+
Va
r
86
.5
6
4.
4
42
8
88
.7
6
0.
9
10
57
8
.3
3
92
.8
6
3.
1
38
8
89
.2
6
1.
0
92
13
.0
4
91
.4
6
4.
0
43
1
89
.8
6
1.
0
10
04
8
.4
6
89
.0
6
4.
9
36
9
89
.2
6
1.
0
95
54
.9
3
89
.4
6
4.
7
43
5
88
.9
6
1.
1
93
89
.8
7
4+
PC
V
65
.8
6
8.
4
32
6
70
.9
6
1.
3
86
76
.2
3
75
.9
6
6.
2
31
6
76
.6
6
1.
4
82
22
.8
3
74
.9
6
6.
3
36
2
81
.4
6
1.
2
92
94
.0
5*
71
.4
6
10
.1
32
2
83
.4
6
1.
2
90
74
.0
3
81
.4
6
5.
9
38
1
84
.2
6
1.
2
89
97
.3
5
4:
3:
1:
3:
3:
1
67
.9
6
11
.1
36
3
77
.8
6
1.
2
93
76
.1
1
80
.0
6
5.
5
32
9
77
.5
6
1.
3
80
97
.3
9
77
.9
6
5.
9
36
4
75
.3
6
1.
4
85
37
.4
1
69
.4
6
8.
2
30
1
69
.2
6
1.
5
72
79
.9
7
69
.3
6
7.
7
34
2
73
.6
6
1.
5
78
98
.2
8
4:
3:
1:
x:
3:
1
69
.0
6
11
.2
36
7
78
.4
6
1.
2
94
39
.1
3
80
.9
6
5.
4
33
2
78
.1
6
1.
3
81
54
.3
3
79
.2
6
5.
8
37
3
78
.2
6
1.
3
88
82
.7
6
75
.3
6
7.
4
32
1
78
.1
6
1.
3
83
84
.4
6
72
.5
6
7.
5
35
8
76
.7
6
1.
4
82
19
.2
8
4:
3:
1:
3:
3:
1:
4
51
.2
6
10
.0
51
2
62
.7
6
1.
4
11
96
1
.0
5
70
.7
6
6.
7
28
5
67
.0
6
1.
6
71
26
.3
0
66
.6
6
6.
9
31
7
68
.2
6
1.
5
78
04
.6
6
52
.3
6
9.
8
26
4
64
.1
6
1.
5
67
95
.0
3
66
.7
6
7.
7
32
0
69
.9
6
1.
6
75
20
.4
3
4:
3:
1:
x:
3:
1:
4
52
.1
6
10
.1
28
8
63
.0
6
1.
4
76
47
.0
6
70
.7
6
6.
7
28
5
67
.4
6
1.
5
71
62
.3
5
67
.8
6
6.
8
32
5
70
.7
6
1.
4
81
05
.4
1
58
.1
6
10
.0
28
2
72
.4
6
1.
4
78
16
.0
1
69
.8
6
7.
6
33
5
72
.7
6
1.
5
78
09
.4
7
*
P
5
.0
47
.
a
AI
/A
N
de
fi
ne
d
as
no
n-
Hi
sp
an
ic
Am
er
ic
an
In
di
an
/A
la
sk
a
Na
tiv
e
al
on
e
or
in
co
m
bi
na
tio
n
w
ith
an
y
ot
he
r
ra
ce
.W
hi
te
de
fi
ne
d
as
no
n-
Hi
sp
an
ic
w
hi
te
on
ly
.
e1596 GROOM et al
 
and the use of public health nurses to
support immunization activities.1,4,5 In
addition, higher immunization cover-
age among Alaska Natives compared
with whites in Alaska has been noted
in previous years5,26 and is likely a re-
sult of the collaborative efforts be-
tween state and tribal entities to
deliver immunizations in remote Alaska
Native villages.
Disparities present nationally in 2006
for the 4:3:1:3:3:1:4 series and in 2008
and 2009 for 4+ doses of PCV (which
alsocontributed to lowercoveragewith
the 4:3:1:3:3:1:4 and 4:3:1:x:3:1:4 series
in 2009) were not present in 2010. We
could not determine if these differ-
ences were true differences or were
due to random fluctuations in esti-
mates from year to year. The sample
size of AI/AN children is relatively small
in the NIS in any one year, leading to
large CIs around the estimates. Addi-
tionally, numerous statistical compar-
isons were made in this study with no
correction made for multiple compar-
isons; therefore, some comparisons
are likely to be statistically significant
by chance alone. However, because the
4+PCV differences were found for 2
consecutive years, they may be more
likely to have been true differences. It is
unclear why coverage would have been
lower for AI/AN children than for white
children in 2008 and 2009, but it may be
that coverage among AI/AN children
was not increasing at the same rate as
coverage among white children (Fig 1).
Because certain AI/AN populations have
an elevated rate of invasive pneumococ-
cal disease compared with other pop-
ulations,1 maintaining high PCV coverage
for AI/AN children is important. In addi-
tion, while coverage at 2 years of age is
helpful for monitoring disparities, look-
ing at timeliness of vaccination before 2
years of age may provide additional in-
sight. Future studies to examine the
timeliness of vaccination in this pop-
ulation are needed.
Because the NIS is a random-digit-dial
survey that samples at the proportion
present in the population, the sample
size of AI/AN children is relatively
small each year. Other mechanisms
for measuring vaccination coverage
among the AI/AN population include the
IHS data and state immunization reg-
istries. Vaccination coverage among AI/
AN children tracked by IHS is limited to
those receiving care through I/T/U fa-
cilities. Immunization registries have
the potential to provide more complete
data on AI/AN children regardless of
where they receive care and, as was
done in North Dakota,6 can help to
identify disparities at the local level
that may not be present in national
level estimates. Identifying local pock-
ets of underimmunized children is im-
portant as regional differences exist
and strategies to improve vaccination
coverage for the AI/AN population may
differ depending on where children are
receiving care. Improving exchange of
data between state immunization reg-
istries and I/T/U facilities could help
ensure more complete data on the AI/
AN population to allow for these types
of assessments.
This report’s findings are subject to at
least 5 limitations. First, before 2011,
NIS was a landline telephone survey;
although statistical weights adjust for
nonresponse and nonlandline tele-
phone households, as well as in-
terruption in telephone service, some
bias might remain. Second, although
NIS relies on provider-verified vacci-
nation histories, incomplete records
and reporting could result in under-
estimates of coverage. Third, the ex-
clusion of Hispanic AI/AN children may
FIGURE 1
Vaccination coverage of AI/AN and white-only children, NIS, 2006–2010, United States. AI/AN defined as non-Hispanic American Indian/Alaska Native alone or in
combination with any other race. White defined as non-Hispanic white only. *P, .05 for comparison of AI/AN versus white children. **3+Hibmeasure that does
not take brand into account.
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have produced some bias by exclud-
ing children of mixed Hispanic-AI/AN
parents. Fourth, the sample size of AI/
AN children in any one year of the NIS is
small, resulting in large CIs for the
estimates. Because of the small sample
size, there is much lower statistical
power to detect small differences in
vaccination coverage between AI/AN
and other children, especially at sub-
national levels. Last, a large number of
statistical comparisons were made in
this study and thus some were likely to
be statistically significant by chance
alone.
CONCLUSIONS
Thegains in vaccination coverage found
in 2005 by a previous study have been
maintained.4 The absence of dis-
parities in coverage with most vac-
cines between AI/AN children andwhite
children from 2006 through 2010 is
a clear success, although the ongoing
presence of risk factors related to
underimmunization and disparities in
PCV coverage for 2 years highlights the
need to continue these types of peri-
odic reviews.
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